| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 10/13/2004 | EP1465645A1 A novel herbal chemical composition for the treatment of cancer |
| 10/13/2004 | EP1465642A1 Protection against the neurotoxicity of oxaliplatin through the administration of calcium and magnesium |
| 10/13/2004 | EP1465635A2 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues |
| 10/13/2004 | EP1465633A1 Quinazolinone compounds in combined modalities for improved cancer treatment |
| 10/13/2004 | EP1465632A1 Quinazoline derivatives for the treatment of abnormal cell growth |
| 10/13/2004 | EP1465631A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 10/13/2004 | EP1465630A1 Cyclic urea derivatives with 5-ht2c receptor activity |
| 10/13/2004 | EP1465626A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 10/13/2004 | EP1465625A2 Solubilized topoisomerase poisons |
| 10/13/2004 | EP1465624A1 Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof |
| 10/13/2004 | EP1465623A1 Urea derivatives |
| 10/13/2004 | EP1465622A1 Use of ppar activators for the treatment of pulmonary fibrosis |
| 10/13/2004 | EP1465616A1 Treatment of statin side effects using uridine derivatives |
| 10/13/2004 | EP1465614A2 A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
| 10/13/2004 | EP1465610A1 Use of a gsk-3beta inhibitor in the manufacture of a medicament for increasing bone formation |
| 10/13/2004 | EP1465609A2 Modulation of dopaminergic neurons |
| 10/13/2004 | EP1465605A1 Pravastatin pharmaceutical formulations and methods of their use |
| 10/13/2004 | EP1465599A1 Liposome composition for delivery of nucleic acid |
| 10/13/2004 | EP1465596A1 Polymeric gel system for the controlled delivery of codrugs |
| 10/13/2004 | EP1465591A1 Antibiotic product, use and formulation thereof |
| 10/13/2004 | EP1465521A2 System and method for the pretreatment of the endplates of an intervertebral disc |
| 10/13/2004 | EP1465504A1 Matrix-forming composition containing pectin |
| 10/13/2004 | EP1430031A4 Kinetic resolution of a intermediate useful in the production of benazepril and analogues thereof |
| 10/13/2004 | EP1397137A4 Hydantion derivatives as inhibitors of matrix metalloproteinases |
| 10/13/2004 | EP1361897A4 Methods for inhibiting pain |
| 10/13/2004 | EP1280820B1 Anti-inflammatory compounds and uses thereof |
| 10/13/2004 | EP1280797B1 Inhibitors of dipeptidyl peptidase iv |
| 10/13/2004 | EP1268472B1 3-aminopyrazole inhibitors of cyclin dependent kinases |
| 10/13/2004 | EP1261346A4 Modulation of cardiovascular injury |
| 10/13/2004 | EP1207840B1 Pharmaceutical compositions and methods for reducing the appearance of cellulite |
| 10/13/2004 | EP1206436B1 Retinoids for the treatment of emphysema |
| 10/13/2004 | EP1202965B1 Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 10/13/2004 | EP1202628B1 Novel hypoxanthine and thiohypoxanthine compounds |
| 10/13/2004 | EP1169038A4 Cyclic protein tyrosine kinase inhibitors |
| 10/13/2004 | EP1165533B1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 10/13/2004 | EP1154786B1 Compositions for altering mucus secretion |
| 10/13/2004 | EP1150954B1 Anti-imflammatory indole derivatives |
| 10/13/2004 | EP1131340B1 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
| 10/13/2004 | EP1107746B1 Methods of using and compositions comprising dopamine reuptake inhibitors |
| 10/13/2004 | EP1107745B1 Use of 5ht-6 antagonists for the treatment of adhd |
| 10/13/2004 | EP1086086B1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 10/13/2004 | EP0986389B1 Novel process |
| 10/13/2004 | EP0802912B1 Piperidine derivatives having tachykinin antagonist activity |
| 10/13/2004 | EP0736036B1 Kininogen inhibitors |
| 10/13/2004 | EP0637933B1 Method for treating organs and tissues |
| 10/13/2004 | CN1537167A Von willebrand factor (VWF)-cleaving enzyme |
| 10/13/2004 | CN1537114A Nitrogenous heterocyclic derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor |
| 10/13/2004 | CN1537112A Pyrimidine compound |
| 10/13/2004 | CN1537111A Urea substituted imidazoquinolines |
| 10/13/2004 | CN1537105A Quinazolines as MMP-13 inhibitors |
| 10/13/2004 | CN1537104A Pyrimidine derivatives useful as selective COX-2 inhibitors |
| 10/13/2004 | CN1537103A Kinetic resolution of intermediater body for preparing benazepril and its analogues |
| 10/13/2004 | CN1537102A Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 10/13/2004 | CN1537101A Pyridine matrix metalloproteinase inhibitors |
| 10/13/2004 | CN1537100A Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 10/13/2004 | CN1537094A Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
| 10/13/2004 | CN1537093A Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 10/13/2004 | CN1537025A 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1.1-dioxo-1 lambda b-thiomorpholin-4-yl)-4-(methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-N-methyl-isobutyramide |
| 10/13/2004 | CN1537019A Medical combination of aldosterone receptor antagonist and HMG CoA reductase inhibitor |
| 10/13/2004 | CN1537017A Remedie for inflammatory bowel diseases |
| 10/13/2004 | CN1537014A HMGB1 protein inhibitors and/or antagonisis for treatment vascular diseases |
| 10/13/2004 | CN1537008A Pharmaceutical combination comprising either (S)-20ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl}ethoxy)phenyl] propanoic acid |
| 10/13/2004 | CN1537004A Compositions containing imidazotriazinone for nasal application |
| 10/13/2004 | CN1537002A Novel theterocyclic analogs of diphenylethylene compounds |
| 10/13/2004 | CN1537001A Malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 10/13/2004 | CN1537000A Novel imidazolidine derivatives, their preparation and their use as VLA-4 antagonists |
| 10/13/2004 | CN1536999A Crystalline forms |
| 10/13/2004 | CN1536997A Crystalline composition containing escitalopram |
| 10/13/2004 | CN1536995A Antitumor compositions containing taxane derivatives |
| 10/13/2004 | CN1536989A Oral compositions comprising host-respones modulating agent for promoting whole body health |
| 10/13/2004 | CN1535978A Circular muscle glycoside diphosphoethoxymethyl ribose compound |
| 10/13/2004 | CN1535971A Fermentation preparation method of cell inhibitor and its crystal form |
| 10/13/2004 | CN1535968A Tetrahydro pyridyl or pyridyl heterocycle derivative |
| 10/13/2004 | CN1535957A New isoquinoline compounds, their preparation method and medicine composition contaning them |
| 10/13/2004 | CN1535731A New dressing matorial for promoting quick repair of surface of dermal wound |
| 10/13/2004 | CN1535728A Drug composition for curing disease produced from IL-6 |
| 10/13/2004 | CN1535710A Yuanbaofeng nervonic acid soft capsule and its preparation process |
| 10/13/2004 | CN1535707A Isatis root extract composition, its preparation method and application |
| 10/13/2004 | CN1535705A Medicinal components composition for preventing dehydration reaction |
| 10/13/2004 | CN1535702A Antifatigue medicine and its preparation method |
| 10/13/2004 | CN1535701A Medicine composition for curing splenomegaly |
| 10/13/2004 | CN1535695A Locust form making method and antifatigue application of its powder |
| 10/13/2004 | CN1535693A Health-preserving liquor with functions of making human body weight be lost and relaxing muscle and its special-purpose additive |
| 10/13/2004 | CN1535688A Combined preparation containing morpholine anthracene nucleus compound and autcancer preparation |
| 10/13/2004 | CN1170933C Motilin homologs |
| 10/13/2004 | CN1170849C Connective tissue growth factor fragments and methods and uses thereof |
| 10/13/2004 | CN1170842C New amidinobenzylamine derivatives and their use as thrombin inhibitors |
| 10/13/2004 | CN1170822C Imidazole compounds and medicinal use thereof |
| 10/13/2004 | CN1170819C Piperidine alcohols |
| 10/13/2004 | CN1170811C Branched chain amino acid-dependent aminotransferase inhibitors and their use in treatment of diabetic retinopathy |
| 10/13/2004 | CN1170593C Immunogenic compsns to CK-b/gastrin-receptor and methods for treatment of tumors |
| 10/13/2004 | CN1170585C Remedies for nervous diseases |
| 10/13/2004 | CN1170578C Medicine composition for improving memory and intelligence |
| 10/13/2004 | CN1170569C New use of tea extractive by soaking |
| 10/13/2004 | CN1170558C Medicine for treating thrombocytopenia and its application in treating radiation disease |
| 10/13/2004 | CN1170551C Hypoglycemic, antihypertensive and antisenility powder for dietotherapy and its preparing process |
| 10/13/2004 | CN1170543C Use of PEG-IFN-alpha and triazloe nucleoside for treatment of chronic hepatitis C |
| 10/13/2004 | CN1170538C Farnesyl protein transferase inhibitors for treating arthropathies |
| 10/13/2004 | CN1170535C Use of medicine for treatment of migraikne by the administration of alpha-lipoic acid |
| 10/13/2004 | CN1170534C Pharmaceutical compositions containing lipase inhibitors |